CuraScientific Corp
CSTF · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -47.8% | – | – | – |
| Gross Profit | -$0 | $0 | -$0 | -$0 |
| % Margin | -245.6% | 50.2% | – | – |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -2,117.8% | 9,422.5% | – | – |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -2,482.5% | 9,351.4% | – | – |
| EPS Diluted | -0.008 | 0.29 | -0.032 | -0.25 |
| % Growth | -102.6% | 1,014.8% | 87.3% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |